2HQ0.XETRA Tilray Brands, Inc.
- Market cap
- EUR 367M
- P/E
- -
- P/B
- 0.27x
- ROE
- -10.5%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Aug 2026.
Is 2HQ0.XETRA undervalued?
Graham numberThe Graham number of Tilray Brands, Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Tilray Brands, Inc. fundamental analysis
No fundamental analysis for Tilray Brands, Inc. yet.
Tilray Brands, Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Tilray Brands, Inc.
Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and distributes pharmaceutical and wellness products; and produces, markets, and se…
Full company profileTilray Brands, Inc. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Aug 31, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Tilray Brands, Inc. annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 628M | 627M | 789M | 821M | 914M | 1.01B |
| Gross Profit | 117M | 147M | 223M | 241M | 241M | 280M |
| Operating Income | -610M | -1.37B | -175M | -2.28B | -54.7M | -63.1M |
| EBITDA | -246M | -1.27B | -72.8M | -2.13B | 12.8M | 10.3M |
| Net Income | -477M | -1.45B | -245M | -2.19B | -121M | -170M |
| EPS | -9.91 | -24 | -3.63 | -25 | -1.08 | -1.27 |
| Balance Sheet | ||||||
| Total Assets | 5.45B | 4.31B | 4.22B | 2.07B | 2.33B | 2.32B |
| Total Liabilities | 1.01B | 977M | 778M | 585M | 732M | 720M |
| Shareholders' Equity | 4.40B | 3.32B | 3.44B | 1.51B | 1.61B | 1.62B |
| Cash & Short-term Investments | 416M | 449M | 261M | 256M | 234M | 221M |
| Total Debt | 624M | 590M | 387M | 329M | 398M | 371M |
| Cash Flow | ||||||
| Operating Cash Flow | -177M | 7.91M | -30.9M | -94.6M | -69.4M | -65.2M |
| Capital Expenditure | 34.1M | 20.8M | 29.2M | 32.9M | 32.9M | 43.4M |
| Free Cash Flow | -211M | -12.9M | -60.2M | -128M | -102M | -109M |
| Ratios | ||||||
| ROE | -10.8% | -43.8% | -7.1% | -144.7% | -7.5% | -10.5% |
| ROA | -8.7% | -33.7% | -5.8% | -105.4% | -5.2% | -7.3% |
| Net Profit Margin | -75.9% | -231.6% | -31.1% | -266.3% | -13.3% | -16.8% |
| Debt to Equity | 0.14x | 0.18x | 0.11x | 0.22x | 0.25x | 0.23x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Tilray Brands, Inc. dividends
Tilray Brands, Inc. has not paid dividends in the last 5 fiscal years.
Last stock split: 1:10 on Dec 2, 2025.
Who owns Tilray Brands, Inc.
- Insiders 1.59%
- Institutions 10.24%
- Public & others 88.18%
- Shares outstanding 148M
- Free float 144M
Tilray Brands, Inc. company profile
- Company name
- Tilray Brands, Inc.
- Ticker
- 2HQ0.XETRA
- Exchange
- XETRA Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 3,595
- Fiscal year end
- May
- Address
- 265 Talbot Street West, Leamington, ON, Canada, N8H 5L4
- Phone
- 844 845 7291
- Website
- tilray.com
About Tilray Brands, Inc.
Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and distributes pharmaceutical and wellness products; and produces, markets, and sells beverage products, and hemp-based food products. In addition, the company provides entertainment products. It offers its products under the Tilray, Aphria, Broken Coast, Symbios, Navcora, Tilray Craft, Charlotte's Web, Shock Top, Montauk Brewing, 10 Barrell, Breckenridge Brewery, SweetWater Brewing, Breckenridge Distillery, Blue Point, Alpine, Broken Coast, Redecan, XMG, Manitoba Harvest, CC Pharma, Good Supply, Solei, Mollo, Chowie Wowie, Original Stash, Canaca, RIFF, Tilray Medical, Bake Sale, The Batch, HEXO, Cruisies, Atwater Brewery, Hi-ball Energy, Liquid Love, Hop Valley Brewing, Redhook Brewery, Revolver Brewing, Square Mile Cider, Mock One, Widmer Brothers Brewing, Runner's High Brewing Company, SweetWater Brewing Company, Terrapin brands. The company sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. and changed its name to Tilray Brands, Inc. in January 2022. Tilray Brands, Inc. is headquartered in Leamington, Canada.
Tilray Brands, Inc. management
10- Mr. Irwin David SimonPresident, CEO & Chairman · born 1958
- Mr. Carl A. Merton CA, CBV, CPACFO & Principal Accounting Officer · born 1970
- Mr. Roger SavellChief Administrative Officer & CFO of International · born 1962
- Mr. Mitchell S. Gendel J.D.Global General Counsel & Corporate Secretary · born 1966
- Ms. Denise Menikheim FaltischekChief Strategy Officer and Head of M&A · born 1973
- Mr. Lloyd BrathwaiteChief Information Officer
- Ms. Berrin NoorataChief Corporate Affairs Officer
- Mr. Blair MacNeil CMA, CPAPresident of Tilray Canada
- Mr. Rajnish OhriPresident of International · born 1962
- Mr. Prinz M. PinakattChief Growth Officer of Tilray Beverages